logo-loader

Cellmid Limited

Receive alerts
Market:
ASX
Market Cap:
$18.84 m
Price
0.20 AUD
Change
2.63%
52 weeks high
0.29
52 weeks low
0.17

In brief

Cellmid Ltd (ASX:CDY) is an Australian life sciences company with lead programs in multiple disease indications.

Deep dive We explore the investor case for growth companies

Snapshot

  • Life science company
  • Develops products to treat conditions associated with aging
  • Two subsidiaries, Lyramid and Advangen